国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Acinetobacter sp. 30S ribosomal protein S13 (rpsM) CSB-YP739108AWW
CSB-EP739108AWW
CSB-BP739108AWW
CSB-MP739108AWW
CSB-EP739108AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. UPF0761 membrane protein ACIAD3168 (ACIAD3168), partial CSB-YP739109AWW1
CSB-EP739109AWW1
CSB-BP739109AWW1
CSB-MP739109AWW1
CSB-EP739109AWW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. UPF0758 protein ACIAD3126 (ACIAD3126) CSB-YP739110AWW
CSB-EP739110AWW
CSB-BP739110AWW
CSB-MP739110AWW
CSB-EP739110AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. UPF0042 nucleotide-binding protein ACIAD3059 (ACIAD3059) CSB-YP739111AWW
CSB-EP739111AWW
CSB-BP739111AWW
CSB-MP739111AWW
CSB-EP739111AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. 50S ribosomal protein L13 (rplM) CSB-YP739112AWW
CSB-EP739112AWW
CSB-BP739112AWW
CSB-MP739112AWW
CSB-EP739112AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. Aspartate 1-decarboxylase (panD) CSB-YP739113AWW
CSB-EP739113AWW
CSB-BP739113AWW
CSB-MP739113AWW
CSB-EP739113AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. Ribosomal RNA large subunit methyltransferase E (rlmE) CSB-YP739114AWW
CSB-EP739114AWW
CSB-BP739114AWW
CSB-MP739114AWW
CSB-EP739114AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. Phosphoribosylformylglycinamidine cyclo-ligase (purM) CSB-YP739115AWW
CSB-EP739115AWW
CSB-BP739115AWW
CSB-MP739115AWW
CSB-EP739115AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. 7-cyano-7-deazaguanine synthase (queC) CSB-YP739116AWW
CSB-EP739116AWW
CSB-BP739116AWW
CSB-MP739116AWW
CSB-EP739116AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. UvrABC system protein B (uvrB), partial CSB-YP739117AWW
CSB-EP739117AWW
CSB-BP739117AWW
CSB-MP739117AWW
CSB-EP739117AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. UPF0317 protein ACIAD2519 (ACIAD2519) CSB-YP739118AWW
CSB-EP739118AWW
CSB-BP739118AWW
CSB-MP739118AWW
CSB-EP739118AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. 30S ribosomal protein S18 (rpsR) CSB-YP739119AWW
CSB-EP739119AWW
CSB-BP739119AWW
CSB-MP739119AWW
CSB-EP739119AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. UPF0756 membrane protein ACIAD2383 (ACIAD2383), partial CSB-YP739120AWW1
CSB-EP739120AWW1
CSB-BP739120AWW1
CSB-MP739120AWW1
CSB-EP739120AWW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. Lipid A export ATP-binding/permease protein MsbA (msbA), partial CSB-YP739121AWW1
CSB-EP739121AWW1
CSB-BP739121AWW1
CSB-MP739121AWW1
CSB-EP739121AWW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. Serine hydroxymethyltransferase (glyA) CSB-YP739122AWW
CSB-EP739122AWW
CSB-BP739122AWW
CSB-MP739122AWW
CSB-EP739122AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. Phosphoribosylglycinamide formyltransferase 2 (purT) CSB-YP739123AWW
CSB-EP739123AWW
CSB-BP739123AWW
CSB-MP739123AWW
CSB-EP739123AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (ispD) CSB-YP739124AWW
CSB-EP739124AWW
CSB-BP739124AWW
CSB-MP739124AWW
CSB-EP739124AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. tRNA (uracil (54)-C (5))-methyltransferase (trmA) CSB-YP739125AWW
CSB-EP739125AWW
CSB-BP739125AWW
CSB-MP739125AWW
CSB-EP739125AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. Ribosome-recycling factor (frr) CSB-YP739126AWW
CSB-EP739126AWW
CSB-BP739126AWW
CSB-MP739126AWW
CSB-EP739126AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Acinetobacter sp. Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP739127AWW
CSB-EP739127AWW
CSB-BP739127AWW
CSB-MP739127AWW
CSB-EP739127AWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>